Is TB-500 Legal in Pennsylvania? Federal Law, State Rules, and How to Get It

HealthRX.com

Federal materials do not establish TB-500 is legal in Pennsylvania

Print or save as PDF

See the public record for TB-500

  • FDA approval / None; FDA found no approved drug containing TB-500 in the US and no approved product in Canada, Australia, the UK or the European countries it checked [1]
  • What it is / A synthetic 7-amino-acid fragment (residues 17 to 23) of the 43-amino-acid protein thymosin beta-4 [1]
  • FDA compounding lists / Not on the pharmacy list or the outsourcing-facility list [2][3][4]
  • Advisory committee / Voted July 23, 2026 to add it to the pharmacy list; advice only [7][5]
  • HHS draft policy / No enforcement action intended against certain compounders of TB-500 acetate if conditions are met; not an approval [5][6]
  • Human data / FDA found no article in which TB-500 was given to a person [1]
  • Anti-doping / WADA bans thymosin-beta4 and its derivatives, including TB-500, at all times [8][9]

What federal law says about TB-500

TB-500 is not an FDA-approved drug: FDA's July 2026 review found no USP or National Formulary monograph for it, no FDA-approved drug containing it, and no approved product in Canada, Australia, the UK or the European countries it checked [1]. It is a synthetic 7-amino-acid fragment of thymosin beta-4, and FDA found several salts and derivatives with different active moieties sold under the same name [1].

A state-licensed pharmacy may compound with a bulk drug substance only if it meets a USP or NF monograph, is a component of an FDA-approved drug, or appears on FDA's list of bulk substances that can be used in compounding [4]. TB-500 is on neither that list nor FDA's list for outsourcing facilities, and FDA's category 1 policy of generally not acting against compounders does not cover it [2][3][4]. FDA found no pharmacy marketing a compounded TB-500 product and no outsourcing facility reporting one [1].

FDA staff recommended against adding TB-500 free base or TB-500 acetate to the pharmacy list, citing poor characterization, no human data, no evidence of effectiveness for wound healing, and immunogenicity risk [1]. On July 23, 2026 the Pharmacy Compounding Advisory Committee voted in favor of adding it, against staff's recommendation; the advice is non-binding and listing takes formal rulemaking [7][5].

HHS filed a draft policy on October 28, 2026, scheduled for publication October 30 [5]. It names TB-500 among six peptides, covers TB-500 acetate given by subcutaneous or intramuscular injection, and says HHS does not intend to take enforcement action against a state-licensed pharmacy, federal facility or licensed physician compounding with it if conditions are met, including a patient-specific prescription and a certificate of analysis [5][6]. The notice says it does not establish rights and is not binding on HHS or the public [5].

Sellers offer TB-500 as research-use-only injectable powder in 2 mg to 15 mg vials, alone or blended with BPC-157 [1]. A 'research use only' label does not mean TB-500 is FDA-approved or that its safety in people has been established [1].

What people on Reddit report

Peptide forum posts about the pending FDA advisory review of compounding lists and what it means for whether this peptide can be compounded.

FleaMarketFien24 · BioHackingGuide

You may or may not know about this but the FDA's has a meeting for July 23-24 2026 about peptides like BPC-157, KPV, TB-500, and MOTS-C for the 503A bulks list. That list determines what compounding pharmacies can legally produce.

The original poster reports that an FDA advisory meeting on compounding lists covering this peptide was upcoming and asks how it could change access.

Read the source discussion

RickKarr · BioHackingGuide

The July meeting is definitely worth watching, but it's important to remember that discussion doesn't equal approval. These peptides are currently in a regulatory grey area, not authorized and not banned. If the panel is supportive, the process of adding them to the 503A Bulks List could still take some time.

A commenter says the peptides are in a grey area, neither authorized nor banned, and that a panel vote would not add them to the list quickly.

Read the source discussion

Questions worth asking

Choose the questions you want to keep

Pennsylvania

The federal materials describe FDA approval status, federal compounding-list status and a draft HHS enforcement-discretion policy. They do not establish a Pennsylvania-specific rule for TB-500, so no state-level conclusion can be drawn from them [1][2][3][4][5][6]. Compounded drugs are not FDA-approved, and FDA does not review their safety, effectiveness or quality before marketing [5].

Anti-doping status

WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in S2.3, prohibited at all times, in and out of competition, on both the 2026 and 2027 Lists [8][9].

Check what you know

Think you have it? Try 4 quick questions and see what the article says.

1. According to the article, what must a state-licensed pharmacy meet to compound with a bulk drug substance?

Question 1 of 4

Score: 0 right, 0 of 4 answered

Is TB-500 legal in Pennsylvania?
The federal materials do not establish that it is. TB-500 is not FDA-approved or on FDA's compounding lists [1][2][3][4]. A draft HHS policy describes limited circumstances in which it does not intend to take enforcement action for compounding TB-500 acetate, but the policy is nonbinding and sets no Pennsylvania-specific rule [5][6].
Did the July 2026 advisory vote make TB-500 legal to compound?
The Pharmacy Compounding Advisory Committee voted on July 23, 2026 in favor of adding it to the pharmacy list, but its recommendations are non-binding, TB-500 is not on the list, and listing takes formal rulemaking [7][5].
What dose of TB-500 is used?
There is no approved dose and no human dosing study. The nomination FDA reviewed proposed a 3 mg/mL lyophilized powder for subcutaneous or intramuscular injection [1].
Is TB-500 banned in sport?
Yes. WADA names thymosin-beta4 and its derivatives, including TB-500, in S2.3, banned at all times in and out of competition, on both the 2026 and 2027 Lists [8][9].
Show all 10 referencesHide references
Evidence overview for Is TB-500 Legal in Pennsylvania? Federal Law, State Rules, and How to Get It